Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gliatech (GLIA) -- Ignore unavailable to you. Want to Upgrade?

To: NeuroInvestment who wrote (632)	2/14/1999 9:36:00 PM
From: scaram(o)uche	Respond to of 2001

thanks, Harry. (eom)

To: NeuroInvestment who wrote (632)	2/14/1999 10:57:00 PM
From: scaram(o)uche	Respond to of 2001

Steve3338 pointed at this from the Yahoo! thread....... biz.yahoo.com 243% surprise (43% relative to my target of $0.07). 243% surprise. Next year consensus estimate, $0.79. Yahoo!

To: NeuroInvestment who wrote (632)	3/2/1999 12:25:00 AM
From: scaram(o)uche	Read Replies (2) \| Respond to of 2001

Yup, Harry, not only is it Abbott and H3 antagonist-related, it's work with one of the GLIA molecules (not 2331)...... Methods Find Exp Clin Pharmacol 1998 Nov;20(9):771-7 Histaminergic ligands attenuate barrel rotation in rats following unilateral labyrinthectomy. Pan JB, O'Neill AB, Hancock AA, Sullivan JP, Brioni JD Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, IL, USA. jia.bao.pan@abbott.com [Medline record in process] In this paper we present a unilateral labyrinthectomy (UL) surgical procedure in rats that was derived from previous techniques. The utility of this model to assess vestibular dysfunction was evaluated by examining the ability of clinically used histaminergic agents and more selective H3 receptor antagonists to attenuate of UL-induced body rotations. Unilateral labyrinthectomy was performed by injection of ethanol into the rat right inner ear. An elevated body rotation test (EBRT) was used to assess the abnormal rotational behavior induced by UL. Scores of "3" to "0" were used to characterize the degree of abnormal behavior according to the latency of body rotations to begin. Our results demonstrate that: i) 100 microliters ethanol induced robust behavioral changes, which was used in further experiments; ii) the clinically used antivertigo agent, astemizole, significantly reduced the rotational behavior in UL rats; iii) the more potent H3 antagonists, thioperamide and GT-2016, were more efficacious than betahistine, a mixed H3 antagonist and H1 agonist. These results indicate that this model may be a potential tool for testing novel drugs for antivertigo effects and provide better support to the role of the histaminergic system in the control of vestibular function.